Published • loading... • Updated
AstraZeneca Promotes Structured Integration of Quality of Life in the Evaluation of Oncological Drugs - Correspondents
Summary by Corresponsables.com España
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The report proposes to include the patient's perspective and measure emotional well-being and functionality to improve health decisions The entry AstraZeneca promotes structured integration of quality of life in the evaluation of oncological drugs was first published in Correspondents.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
